Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,360.00
Bid: 12,328.00
Ask: 12,332.00
Change: -4.00 (-0.03%)
Spread: 4.00 (0.032%)
Open: 12,358.00
High: 12,376.00
Low: 12,256.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hundreds queue up as Latvia offers walk-in AstraZeneca shots

Fri, 16th Apr 2021 11:30

By Janis Laizans and Andrius Sytas

RIGA, April 16 (Reuters) - People in their 30s showed up in
their hundreds on Friday morning as Latvia offered the
AstraZeneca vaccine to anyone who wanted it in order to
clear a growing backlog of the shot often refused by the old.

Latvia is now vaccinating people over 65 and those with
chronic illnesses, but many do not show up when told they will
be given AstraZeneca.

Denmark this week became the first country to stop using
AstraZeneca altogether, as European officials investigate
reports of rare blood clots. Many countries have resumed using
the shot, with some restricting it to certain age groups, mostly
those aged above 50 or above 60.

“We queued two and half hours before opening, around 6:30 in
the morning, because this is the only way out of this for us,”
Riga resident Vladlens Kovalenvs told Reuters at a converted
convention centre in they city.

Partly due to hesitancy over AstraZeneca, Latvia has been
lagging in vaccination, with only 7.8% of adults getting at
least a single dose by Sunday, the worst result in the European
Union, according to European Centre for Disease Control and
Prevention.

A total of about 8,000 doses were distributed to seven
vaccination centres around the country, to be used over the
weekend, in one of the first open-to-all COVID-19 vaccination
schemes in the EU.

"We had an AstraZeneca surplus and to avoid keeping vaccines
in the warehouse we decided to make this walk-in line open to
anyone", said the chief of Latvia's vaccination programme, Eva
Juhnevica.

Latvia and neighbouring Lithuania asked Denmark to sell them
its leftover vaccines to speed up their own efforts.

In the Lithuanian capital Vilnius, a similar backlog of
vaccines was cleared after being offered to the young, who were
not expecting to get a shot so early.

"People over 65 in Vilnius are extremely reluctant to take
AstraZeneca vaccine - so we began giving them Pfizer vaccine,
and opened up AstraZeneca vaccination to priority groups
containing younger people", Vilnius mayor Remigijus Simasius
told Reuters. "And the vaccination is now going smoothly."
(Reporting by Janis Laizans in Riga and Andrius Sytas in
Vilnius
Writing by Andrius Sytas
Editing by Giles Elgood)

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.